Skip to content

Events
About Us
News
Newsletter

Facebook Linkedin Youtube

Careers
Contacts

COVID-19
Company
Apheresis
Transplantation
Critical care
Pathologies
Therapeutical Solutions
Search for:

Search for:

Quality Policy

Home/Company Overview/Quality Policy

Quality Policyaferetica-pt2020-06-30T09:57:47+02:00

“Download the “Quality Policy” document”

Quality Policy [PDF]

ISO 13485 – ISO 9001

Do you need more information?

Last updates

Recent Posts

The integrated PerLife(R) system with “PerSorb ECOS-300CY™” sorbent obtains CE certification and is ready to enter in the clinical practice.
WEB SYMPOSIUM – 17 ^th November 2020
Purification Therapies – Appointments 2020
Webinar Purification Therapies in the time of Covid-19
F.D.A. (USA) Approved for Emergency CytoSorb® 300 mL Device Treatment of COVID-19

Contacts

Headquarters:

Via Roma 19
40017 San Giovanni in Persiceto (BO)

Tel: +39 0535 640261

Registered Office:

Aferetica s.r.l.
Via Spartaco 10
40138 Bologna

Tel: +39 051 0218370

P.I./VAT 03330561204

Information Request

For more information, contact our Customer Service:

customer.service@aferetica.com

Tel: +39 0535 640263

Fax: +39 051 0218364

Privacy Policy
Cookies Policy

Aferetica

Aferetica proposes itself as a catalyst for the creation of a Network able to create, validate and use Apheretic Therapies in several clinical areas: from Intensive Care, Nephrology, Cardiology, Transfusiology, Gastroenterology to Transplant, with a view to introduce innovation activities for organ’s purification.

Aferetica

Copyright Aferetica srl | All Rights Reserved | Sito internet a cura di BauWeb | Mec&Partners

Facebook LinkedIn YouTube

This website does NOT use any profiling cookie to send you advertising in line with your preferences. Only technical cookies are used. There may be third-party cookies related to videos, maps or social plugins. If you want to know more about the use of cookies on this website and read how to disable them, please read our Cookies Policy. If you access any site element, you consent to cookies to this website. ACCEPT